The Institute of Biomedical Science (IBMS) Congress is the biggest event for the biomedical science workforce in the UK. The 2019 programme included lectures, presentations and workshops across multiple disciplines, showcasing the increasing breadth of biomedical science and its impact on healthcare.
HSL exhibited at the event, raising awareness of its network of state-of-the-art laboratories and training and development opportunities. The stand featured a mini version of the Halo’s GLP track – a unique and highly complex sample tracking system with vertical connectivity across multiple floors – accompanied by a live stream of the real GLP track in action. This proved very popular among delegates and highlighted HSL’s commitment to investing and developing the latest technologies.
David Ricketts, Head of Laboratory Process Improvement, and Wendy Leversuch, Head of Scientific Training, both presented at the conference. David spoke about developing a career pathway for support workers in sample reception, while Wendy discussed how to balance training needs and priorities with limited resources. Starting with a general approach, Wendy explained how to identify and prioritise training needs before using specific examples to illustrate how HSL has put this into practice.
Daniel Simmons, who works in histology at the Royal Free, was delighted to win a prize in the cellular pathology poster competition. This was a fantastic achievement and an excellent opportunity to showcase the work of the PITHIA trial – a clinical trial evaluating the use of pre-implantation kidney biopsies as a tool to improve the quality of renal transplantation.
“Overall the conference was a huge success,” says Wendy. “Our stand was very busy and we spoke to a real mix of delegates working across the profession. It was encouraging to see such a positive response to our labs and the opportunities we provide – particularly for those wishing to complete their registration and specialist portfolios. It was a fantastic few days and we look forward to returning in 2021.”